Drug Type Radiolabeled antibody, Therapeutic radiopharmaceuticals  | 
Synonyms Yttrium 90 RadioTheraCIM  | 
Target  | 
Action antagonists  | 
Mechanism EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists)  | 
Therapeutic Areas  | 
Active Indication-  | 
Inactive Indication  | 
Originator Organization  | 
Active Organization-  | 
Inactive Organization  | 
License Organization-  | 
Drug Highest PhaseDiscontinuedPhase 1  | 
First Approval Date-  | 
Regulation-  | 

| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Glioma | Phase 1 | Cuba   | - | |
| Glioma | Phase 1 | Italy   | - | - | 
| Glioma | Phase 1 | - | - | 






